Matt Davidson
Chief Development Officer, ADIAL PHARMACEUTICALS, INC.
Companies
- ADIAL PHARMACEUTICALS, INC.Board member Jun 16, 2026 to now1
- ADIAL PHARMACEUTICALS, INC.Chief Development Officer Jun 16, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ADIAL PHARMACEUTICALS, INC. ADIL299,414 shares2$1.0M at $3.49Jun 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 12, 2026Granted 232,417 shares of ADIAL PHARMACEUTICALS, INC.2
- Jun 11, 2026Granted 101 shares of ADIAL PHARMACEUTICALS, INC.2
- Jun 11, 2026Granted 1,822 shares of ADIAL PHARMACEUTICALS, INC.2
- Jun 11, 2026Granted 3,427 shares of ADIAL PHARMACEUTICALS, INC.2
- Jun 11, 2026Granted 61,647 shares of ADIAL PHARMACEUTICALS, INC.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2